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Abstract
Human respiratory syncytial virus (RSV) constitute highly pathogenic virus that cause severe respiratory diseases in
newborn, children, elderly and immuno-compromised individuals. Airway inflammation is a critical regulator of disease
outcome in RSV infected hosts. Although ‘‘controlled’’ inflammation is required for virus clearance, aberrant and
exaggerated inflammation during RSV infection results in development of inflammatory diseases like pneumonia and
bronchiolitis. Interleukin-1b (IL-1b) plays an important role in inflammation by orchestrating the pro-inflammatory response.
IL-1b is synthesized as an immature pro-IL-1b form. It is cleaved by activated caspase-1 to yield mature IL-1b that is secreted
extracellularly. Activation of caspase-1 is mediated by a multi-protein complex known as the inflammasome. Although RSV
infection results in IL-1b release, the mechanism is unknown. Here in, we have characterized the mechanism of IL-1b
secretion following RSV infection. Our study revealed that NLRP3/ASC inflammasome activation is crucial for IL-1b
production during RSV infection. Further studies illustrated that prior to inflammasome formation; the ‘‘first signal’’
constitutes activation of toll-like receptor-2 (TLR2)/MyD88/NF-kB pathway. TLR2/MyD88/NF-kB signaling is required for pro-
IL-1b and NLRP3 gene expression during RSV infection. Following expression of these genes, two ‘‘second signals’’ are
essential for triggering inflammasome activation. Intracellular reactive oxygen species (ROS) and potassium (K
+) efflux due
to stimulation of ATP-sensitive ion channel promote inflammasome activation following RSV infection. Thus, our studies
have underscored the requirement of TLR2/MyD88/NF-kB pathway (first signal) and ROS/potassium efflux (second signal)
for NLRP3/ASC inflammasome formation, leading to caspase-1 activation and subsequent IL-1b release during RSV infection.
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Introduction
Human respiratory syncytial virus (RSV) is a RNA respiratory
virus that infects lung epithelial cells to cause high mortality and
morbidity among infants, children and elderly by developing severe
respiratory diseases like pneumonia and bronchiolitis [1–3]. These
diseases occur due to massive and ‘‘uncontrolled’’ inflammation of
the respiratory tract. It is believed that prolonged virus infection (and
resulting high viral replication/multiplication) results in a robust
inflammatory response that is detrimental to the infected host. The
innate immune antiviral response is the first line of defense against
virusinfection beforeinductionofthe adaptive immune response [4–
6]. It is well established that innate response is critical to restrict virus
spread and infection resulting in diminished disease burden. The
inflammatory response constitutes a critical innate defense mecha-
nism triggered by the host to control infections [7]. However,
aberrant and unregulated inflammation results in development of
various disease states including pneumonia and bronchiolitis.
Interleukin-1b (IL-1b) is a critical cytokine that acts as a
pyrogen to amplify the pro-inflammatory response during
infection with various pathogens. IL-1b produced from infected
cells acts via an autocrine/paracrine mechanism to activate NF-
kB/MAP kinase dependent pro-inflammatory cytokines and
chemokines to establish an effective immune response for
combating infection. Respiratory RNA viruses like RSV and
influenza A virus induce secretion of IL-1b in the respiratory tract
during infection of mouse and humans and its secretion is critical
for ‘‘shaping’’ the anti-viral inflammatory response to clear virus
from the airway [8–12]. Production of IL-1b from macrophages
requires three steps – a) expression of pro-IL-1b gene and synthesis
of immature pro-IL-1b protein, b) processing (cleavage) of pro-IL-
1b by active caspase-1 to yield the mature form of IL-1b, and c)
secretion of mature IL-1b from the cell to the extracellular
environment via Rab-3a containing secretory vesicle [13].
Generation of mature IL-1b is achieved following cytoplasmic
assembly and activation of inflammasomes [14–19]. The NLR
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masome is a multi-protein complex comprising of caspase-1, NLR
proteins and adaptor protein ASC (apoptosis-associated speck-like
protein containing a caspase recruitment domain) [20–22]. The
well characterized NLR inflammasome complex constitutes NLR
protein NLRP3 (NOD-like receptor family, pryin domain
containing 3; also known as NALP3 and cryopyrin), ASC and
caspase-1. Oligomerization of NALP3-ASC results in caspase-1
recruitment in the complex, which promotes cleavage of casapase-
1 via auto-catalytic mechanism to generate enzymatically active
hetero-dimer of two p20 and p10 subunits, which are involved in
cleaving the precursor pro-IL-1b into its mature secreted form
[14–22]. Various stress signals culminates in formation of
inflammasome complex during diverse patho-physiological condi-
tions/disease like infection, cardiovascular disease, metabolic
disorder (e.g. diabetes), and inflammatory diseases (arthritis, gout)
[14–37].
During stress response, macrophages need two signals for
inflammasome complex formation and subsequent caspase-1
activation [38]. First signal (signal-1) ensures adequate gene/
protein expression of pro-IL-1b and inflammasome components
(e.g. NLRP3 etc); while second signal (signal-2) is required for
inflammasome complex assembly and subsequent caspase-1
activation leading to cleavage of pro-IL-1b into its mature form.
Following cellular insult, signal-1 is mediated by stimulation of
pattern recognition receptors (PRRs) (e.g. toll-like receptors or
TLRs, NOD-like receptors like Nod2) via Pathogen Associated
Molecular Patterns (PAMPs) or Damage Associated Molecular
Patterns (DAMPs) which are specific ‘‘molecular’’ or ‘‘chemical’’
signature associated with the cellular stimuli [21,22,39]. PRR
induction results in activation of NF-kB pathway for expression of
pro-IL-1b and inflammasome related protein genes. While signal-
2 is conferred by either – a) generation of intracellular reactive
oxygen species (ROS), b) potassium efflux due to stimulation of
ATP-sensitive potassium channel or pore formation by bacterial
toxins, and c) lysosomal disintegration leading to leakage of
cathepsin B in the cytosol [14–19,29].
Although RSV infection results in IL-1b secretion [9–12], the
mechanism of IL-1b activation has not been elucidated yet.
Recently we identified Nod2 (a member of NLR family of
receptors) as a competent of innate antiviral response against RSV
[40]. Since NLRs like NLRP3 is a component of inflammasome
complex [14–37], we investigated – a) the requirement of activated
caspase-1 for IL-1b secretion during RSV infection, b) the nature
of NLR inflammasome complex assembled following RSV
infection, c) the role of PRRs and NF-kB pathway in expression
of pro-IL-1b and inflammasome related genes during RSV
infection (signal-1), and d) the specific mechanism responsible for
triggering activation of inflammasome complex (signal-2). Our
study revealed that during RSV infection NLRP3-ASC inflamma-
some is required for caspase-1 activation and mature IL-1b
secretion. RSV mediated activation of TLR2/MyD88 signaling is
critical for expression of pro-IL-1b and NLRP3 genes via NF-kB
dependent pathway (signal-1). Both ROS generated during RSV
infection and potassium efflux following stimulation of ATP-
sensitive potassium channel serve as the second signal (signal-2) for
inflammasome mediated generation of mature IL-1b due to
cleavage of pro-IL-1b by activated caspase-1. Thus our results
have underscored the requirement of TLR2-MyD88-NF-kB
pathway and NLRP3-ASC inflammasome in IL-1b release during
RSV infection. Furthermore, we have identified both ROS and
potassium efflux (due to stimulation of potassium channel) as the
intracellular signal essential for triggering inflammasome activa-
tion and IL-1b production during infection.
Results
Caspase-1 is required for IL-1b production during RSV
infection
The role of caspase-1 in IL-1b secretion during RSV infection
was examined by over-expressing pro-caspase-1 in 293 cells
(obtained from American Type Culture Collection (ATCC),
Manassas, VA) that endogenously express low levels of pro-
caspase-1. 293 cells were transfected with pro-IL-1b, pro-caspase-
1 or pcDNA (control) plasmids. Twenty four hour post-
transfection, cells were infected with RSV. At 12 h post-infection,
the medium supernatant was collected to assess levels of secreted
IL-1b by ELISA. Expression of pro-IL-1b and pro-caspase-1 in
transfected 293 cells was confirmed by RT-PCR (data not shown).
Pro-IL-1b expression was similar in pro-IL-1b+pcDNA transfect-
ed cells and pro-IL-1b+pro-caspase-1 transfected 293 cells (data
not shown). Caspase-1 was required for IL-1b production during
RSV infection, since higher levels of secreted IL-1b was detected
in pro-caspase-1 expressing cells (i.e. pro-caspase-1+pro-IL-1b)
compared to control cells (i.e. cells transfected with pcDNA+pro-
IL-1b) (Fig. 1A). There was an enhancement of IL-1b production
by 300 pg/ml following expression of caspase-1 in 293 cells
(Fig. 1A). Low levels of basal IL-1b release in pro-caspase-1 non-
transfected cells (Fig. 1A) could be due to activation of endogenous
pro-caspase-1 in 293 cells. However, we failed to detect caspase-1
in mock infected and RSV infected 293 cells (Fig. S1A). Similarly,
pro-IL-1b was not expressed in 293 cells (Fig. S1B). Caspase-1
(Fig. S1A) and pro-IL-1b (Fig. S1B) expression was only detected
following transfection of pro-caspase-1 and pro-IL-1b. Thus, basal
IL-1b production from 293 cells could be due to an alternative
mechanism, which is yet to be characterized. Moreover, non-
infected (mock) cells transfected with pro-IL-1b and pro-caspase-1
secreted very low levels (less than 10 pg/ml) of IL-1b (data not
shown), which could be attributed to either self activation of
caspase-1 or activation of alternate discrete signaling in 293 cells.
To establish the physiological role of caspase-1, we next
evaluated the requirement of endogenous caspase-1 in IL-1b
production. For these studies we utilized human macrophage-like
U937 cell-line (obtained from American Type Culture Collection
(ATCC), Manassas, VA), since macrophages constitutes the major
source of IL-1b during respiratory virus infection. Inhibition of
caspase-1 by specific caspase-1 inhibitor Ac-YVAD-CHO [41]
resulted in drastic reduction in IL-1b secretion following RSV
infection for 12 h (Fig. 1B). These studies were further extended to
primary macrophages isolated from mice. Similar to U937 cells,
treatment of mouse bone marrow derived macrophages (BMDM)
with caspase-1 inhibitor Ac-YVAD-CHO resulted is loss of IL-1b
production from RSV infected cells (Fig. 1C). The release of IL-1b
from RSV infected U937 and BMDMs at 12 h–24 h post-
infection was not due to cell death (apoptosis, pyroptosis or
necrosis) because annexin-V and Propidium Iodide (PI) staining
(representative of cell death) was not observed in RSV infected (at
12 h–24 h post-infection) U937 cells and BMDMs (data not
shown). Annexin-V staining was noted only at 48 h post-infection.
Interestingly, we failed to detect IL-1b secretion from RSV
infected human epithelial cell-lines [human lung epithelial A549
(obtained from American Type Culture Collection (ATCC),
Manassas, VA) cells and Hela (obtained from American Type
Culture Collection (ATCC), Manassas, VA) cells (data not shown).
In contrast, normal human bronchial epithelial (NHBE) primary
cells (obtained from Lonza, Walkersville, MD) which are one of
the primary targets of RSV during productive infection of human
lungs produced IL-1b following RSV infection (Fig. S2). The IL-
1b release was due to caspase-1 activation, since inhibition of
Inflammasome Activation during RSV Infection
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cally reduced IL-1b secretion from RSV infected NHBE cells (Fig.
S2).
The result obtained with caspase-1 inhibitor was further
validated by using primary cells that lack caspase-1 expression.
Wild-type (WT) and caspase-1 knock-out (KO) BMDMs were
infected with RSV for 12 h–24 h. At each time-period, IL-1b
secretion was assayed by ELISA analysis of medium supernatants.
Caspase-1 expression is vital for IL-1b release, since levels of IL-1b
was drastically diminished in the medium supernatant of infected
caspase-1 KO cells compared to WT cells (Fig. 1D). Thus our
results obtained with macrophage cell-line and primary macro-
phages demonstrated that caspase-1 plays a critical role in mature
IL-1b processing and secretion during RSV infection.
NLRP3 inflammasome is required for IL-1b release during
RSV infection
Caspase-1 activation is mediated by inflammasome complex.
Since IL-1b production during RSV infection was caspase-1
dependent (Fig. 1), we speculated that NLR protein(s) is required
for caspase-1 activation following inflammasome assembly. We
first focused on the NLRP3 since this NLR protein is an important
component of inflammasome complex during infections with
various pathogens, including respiratory viruses like influenza A
virus [30–32]. The role of NLRP3 was evaluated by investigating
IL-1b production from RSV infected 293 cells expressing NLRP3
in trans. 293 cells transfected with pro-IL-1b, pro-caspase-1 and
NLRP3 plasmids were infected with RSV. IL-1b production from
these cells was examined by performing ELISA analysis of the
medium supernatants. NLRP3 plays a role during IL-1b
production, since enhanced IL-1b levels were detected in infected
NLRP3 expressing cells (i.e. NLRP3+pro-caspase-1+pro-IL-1b)
compared to cells transfected with pcDNA (control) (pcDNA+pro-
caspase-1+pro-IL-1b) (Fig. 2A). There was an enhancement of IL-
1b production by 150 pg/ml following expression of NLRP3 in
293 cells (Fig. 2A). Expression of pro-IL-1b, caspase-1 and NLRP3
in transfected 293 cells was confirmed by RT-PCR (data not
shown). Pro-IL-1b and caspase-1 expression was similar in pro-IL-
1b+pro-caspase-1+pcDNA transfected cells and pro-IL-1b+pro-
caspase-1+NLRP3 transfected 293 cells (data not shown). It is
important to mention that RSV infection induced endogenous
NLRP3 expression in 293 cells (Fig. S1C), thus over-expression
Figure 1. Caspase-1 dependent IL-1b release during RSV infection. (A) 293 cells were transfected either with pcDNA (control), pro-IL-1b and/
or pro-caspase-1 plasmids. At 24 h post-transfection, cells were infected with RSV (1 MOI). At 12 h post-infection, medium supernatant was assessed
for IL-1b protein by ELISA analysis. (B) Human macrophagic U937 cells were infected with RSV (1 MOI) in the presence of either water (vehicle control)
or caspase-1 inhibitor (10 mM of Ac-YVAD-CHO). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h post-infection. (C) Primary
mouse bone marrow derived macrophages (BMDM) were infected with RSV (1 MOI) in the presence of either water (vehicle control) or caspase-1
inhibitor (10 mM of Ac-YVAD-CHO). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h post-infection. (D) Wild type (WT) or
caspase-1 knock-out (KO) BMDMs were infected with RSV (1 MOI). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h
post-infection. Each value represents the mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0029695.g001
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of NLRP3 stimulated increased IL-1b production from RSV
infected 293 cells.
The role of NLRP3 during IL-1b secretion was further
validated using mouse primary BMDMs lacking NLRP3 expres-
sion (NLRP3 KO BMDM). WT and NLRP3 KO BMDMs were
infected with RSV and at 12 h and 24 h post-infection time
periods medium supernatant was collected to assess IL-1b levels by
ELISA. As shown in Fig. 2B, NLRP3 expression is critical for IL-
1b secretion since drastic reduction in IL-1b release was observed
in RSV infected NLRP3 KO cells compared to WT cells. These
results demonstrated that NLRP3 is an important component of
the inflammasome complex and therefore, it is required for
optimal caspase-1 activation and IL-1b secretion from RSV
infected cells.
ASC is required for IL-1b secretion during RSV infection
Dissection of the constituents of the inflammasome complex has
revealed that ASC protein serves as a major component of NLRP3
inflammasome. NLRP3/ASC inflammasome complex has been
implicated in caspase-1 activation during various physiological and
pathological conditions. Since we identified NLRP3 as an
important inflammasome complex component during RSV
infection (Fig. 2), we next examined whether ASC/NLRP3
inflammasome is required for IL-1b secretion during RSV
infection. Similar to above studies with NLRP3 (Fig. 2), we
initially evaluated the role of ASC by utilizing pro-IL-1b and pro-
caspase-1 expressing 293 cells. These cells were transfected with
either ASC or pcDNA (control) plasmids. After 24 h post-
transfection, RSV infection was initiated and IL-1b secretion
was measured by performing IL-1b ELISA assay with the medium
supernatants. ASC also serve as an essential factor regulating IL-
1b production, since higher levels of IL-1b was detected in RSV
infected ASC expressing (i.e. ASC+pro-caspase-1+pro-IL-1b) 293
cells compared to pcDNA (control) (i.e. pcDNA+pro-caspase-
1+pro-IL-1b) transfected cells (Fig. 3A). There was an enhance-
ment of IL-1b production by 110 pg/ml following expression of
ASC in 293 cells (Fig. 3A). Expression of pro-IL-1b, caspase-1 and
ASC in transfected 293 cells was confirmed by RT-PCR (data not
shown). Pro-IL-1b and caspase-1 expression was similar in pro-IL-
1b+pro-caspase-1+pcDNA transfected cells and pro-IL-1b+pro-
caspase-1+ASC transfected 293 cells (data not shown). ). Similar to
NLRP3, low levels of endogenous ASC was detected following
RSV infection of 293 cells (data not shown) and ASC over-
expression (following transfection with ASC plasmid) augmented
IL-1b secretion from infected 293 cells.
Mouse primary BMDM that lacks ASC expression (derived
from ASC KO mice) was utilized to further confirm the critical
function of ASC during IL-1b secretion from RSV infected cells.
IL-1b production was evaluated by ELISA analysis of medium
supernatant derived from RSV infected WT and ASC KO cells.
Similar to NLRP3, ASC is also a key player involved in IL-1b
release. We observed significant loss of IL-1b secretion from
infected ASC KO BMDM in comparison to infected WT BMDM
(Fig. 3B). Based on these results and data shown in Fig. 2 we
concluded that NLRP3/ASC inflammasome is indispensible for
efficient IL-1b secretion during RSV infection.
Both NLRP3 and ASC are required for caspase-1
activation following RSV infection
Inflammasome is required for caspase-1 activation and
subsequent release of mature IL-1b. Since NLRP3/ASC inflam-
masome is required for IL-1b secretion (Fig. 2 and 3), we
speculated that it is also required for caspase-1 activation during
RSV infection. The hallmark of inflammasome complex mediated
caspase-1 activation is cleavage of pro-casapase-1 into enzymat-
ically active hetero-dimer of two p20 and p10 subunits. Therefore,
detection of p10 subunit serves as an indicator of inflammasome
complex mediated generation of active caspase-1. In order to
investigate whether NLRP3/ASC is needed for caspase-1
activation, we infected WT, NLRP3 KO and ASC KO BMDMs
with RSV. At 12 h post infection, the cell lysate was subjected to
SDS-PAGE and Western blotting with anti-caspase-1 p10 subunit
specific antibody. Western blot analysis revealed lack of p10 in
infected NLRP3 KO and ASC KO BMDM compared to WT
counterpart (Fig. 4A). Specificity of the p10 product is borne out
by lack of any p10 subunit in mock infected WT cells and in KO
cells. Equal loading was confirmed by re-probing the same blot
after stripping with anti-actin antibody (Fig. S3). Thus, NLRP3/
ASC inflammasome formation is an essential pre-requisite for
Figure 2. IL-1b secretion during RSV infection requires NLRP3 expression. (A) 293 cells were transfected either with pcDNA (control), pro-IL-
1b+pro-caspase-1 plasmids and NLRP3 plasmid. At 24 h post-transfection, cells were infected with RSV (1 MOI). At 12 h post-infection, medium
supernatant was assessed for IL-1b protein by ELISA analysis. (B) Wild type (WT) or NLRP3 knock-out (KO) BMDMs were infected with RSV (1 MOI). IL-
1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. Each value represents the mean 6 standard deviation
from three independent experiments.
doi:10.1371/journal.pone.0029695.g002
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NLRP3/ASC inflammasome in caspase-1 activation was further
confirmed by observing that reduction in IL-1b production from
ASC KO and NLRP3 KO cells (Fig. 2B, 3B) were solely due to
failure in caspase-1 activation, since RT-PCR analysis revealed
similar expression of pro-IL-1b and inflammasome components
(ASC or NLRP3) in RSV infected WT, NLRP3 KO and ASC KO
cells. (Fig. 4B). Our studies have led to identification of ASC/
NLRP3 inflammasome as the essential component required for
caspase-1 activation and IL-1b secretion during RSV infection.
NF-kB signaling is required for expression of pro-IL-1b
and NLRP3 during RSV infection
The transcription factor NF-kB regulates diverse cellular
processes including acting as a trans-activator of genes involved
in innate immune response. NF-kB activation is required for IL-1b
release following stimulus with various PAMPs and DAMPs [42–
45]. It is envisioned that such function of NF-kB is manifested by
various mechanisms including, expression of NLRP3 and pro-IL-
1b genes [42–45]. RSV activates NF-kB during infection [40,46–
50]; however, the role of NF-kB in controlling IL-1b production
during RSV infection has not been examined yet. In order to
investigate whether NF-kB activation is required for IL-1b
production, we inhibited NF-kB activation in infected cells by
using a specific NF-kB inhibitor BAY 11-7082 [42]. U937 cells
were pre-treated with DMSO (vehicle control) or BAY 11-7082
(5 mM) for 2 h, followed by RSV infection in the presence of either
DMSO or BAY 11-7082. At 12 h and 24 h post-infection time-
points, IL-1b levels in the medium supernatant were measured by
ELISA assay. Indeed, NF-kB activation is required for IL-1b
secretion during RSV infection, since significant loss of IL-1b
production was observed upon blocking NF-kB activation
(Fig. 5A). The NF-kB dependent mechanism of IL-1b production
was further probed by investigating expression pro-IL-1b, caspase-
1, and NLRP3 gene expression in BAY 11-7082 treated cells vs.
control cells. For these studies, we treated U937 cells with either
DMSO or BAY 11-7082 as discussed above. Total RNA isolated
from RSV infected cells (+/2 DMSO or BAY 11-7082) were used
for RT-PCR analysis. Our results revealed that during RSV
infection, activated NF-kB is required for expression of several key
genes, including pro-IL-1b and NLRP3. Expression of pro-IL-1b
and NLRP3 was drastically reduced in RSV infected NF-kB
inhibited cells compared to control cells (Fig. 5B). In contrast,
expression of caspase-1 was unaltered upon NF-kB inhibition.
Figure 3. ASC expression is essential for IL-1b production during RSV infection. (A) 293 cells were transfected either with pcDNA (control),
pro-IL-1b+pro-caspase-1 plasmids and ASC plasmid. At 24 h post-transfection, cells were infected with RSV (1 MOI). At 12 h post-infection, medium
supernatant was assessed for IL-1b protein by ELISA analysis. (B) Wild type (WT) or ASC knock-out (KO) BMDMs were infected with RSV (1 MOI). IL-1b
levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. Each value represents the mean 6 standard deviation from
three independent experiments.
doi:10.1371/journal.pone.0029695.g003
Figure 4. NLRP3 and ASC are required for caspase-1 activation following RSV infection. (A) Wild type (WT), NLRP3 knock-out (KO) and
ASC KO BMDMs were infected with RSV (1 MOI) for 12 h. The cell lysate from mock infected and RSV infected cells were subjected to Western blot
analysis with mouse caspase-1 p10 subunit specific antibody. (B) RT-PCR analysis of pro-IL-1b, ASC and NLRP3 expression in RSV infected WT, NLRP3
KO and ASC KO BMDMs. The gels shown in (A) and (B) is representative of three independent experiments that yielded similar results.
doi:10.1371/journal.pone.0029695.g004
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WT mouse BMDM. Similar to U937 cells, NF-kB activation was
critical for IL-1b secretion from RSV infected BMDM. Treatment
of BMDM with BAY 11-7082 resulted in diminished IL-1b
production upon RSV infection (Fig. 5C). The loss of IL-1b
release was due to reduced pro-IL-1b and NLRP3 expression in
NF-kB inhibited cells. RT-PCR analysis revealed drastic reduction
in pro-IL-1b and NLRP3 mRNA expression in RSV infected cells
that were treated with BAY 11-7082 (Fig. 5D). Similar results (i.e.
loss of IL-1b production and reduction in pro-IL-1b and NLRP3
gene expression) with U937 cells and BMDM were obtained by
using another NF-kB specific inhibitor, IKK-2 inhibitor IV
(Calbiochem) (data not shown). The endogenous basal mRNA
levels of pro-IL-1b, NLRP3, ASC and caspase-1 was same in
DMSO treated vs. BAY 11-7082 treated U937 cells and BMDMs
(data not shown). The NF-kB inhibitors (at concentrations used in
the above studies) were not toxic to the cells as cell viability assay
did not show significant loss of cell viability during the time-period
of the experiments described above (data not shown). Moreover,
similar concentrations of BAY 11-7082 were utilized previously to
assess function of NF-kB in macrophages [42]. Our studies have
demonstrated that NF-kB is required for activation of pro-IL-1b
and NLRP3 genes during RSV infection. Thus, NF-kB is a critical
player during initial (signal-1, first signal) process of inflammasome
activation and subsequent mature IL-1b secretion from RSV
infected cells.
TLR2/MyD88 pathway regulates pro-IL-1b and NLRP3
gene expression during RSV infection
During pathogen invasion the ‘‘first signal’’ compromises of
activation of PRR(s) by PAMP(s) leading to NF-kB mediated
expression of pro-IL-1b and inflammasome-associated (e.g.
NLRP3) genes. TLRs are type-I integral membrane PRRs
involved in induction of innate immune response against wide
spectrum of pathogens. MyD88 serves as a major adaptor protein
for TLR-mediated signal transduction. TLR stimulation by
PAMPs culminates in activation of NF-kB, MAPK and IRF3
pathways resulting in expression of pro-inflammatory and antiviral
genes. So far the function of TLRs as the ‘‘first signal’’ for IL-1b
production has been only document for few pathogens including,
Vibrio, Candida albicans, vaccinia virus, fungal components [51–
55]. Since RSV activates TLR signaling (via TLR2 and TLR4)
during infection [56–58], we next investigated whether TLR/
MyD88 pathway is required for IL-1b secretion during RSV
infection. Our result (Fig. 5) showing NF-kB mediated expression
of pro-IL-1b and NLRP3 genes also formed the foundation for
Figure 5. NF-kB signaling is critical for IL-1b secretion during RSV infection. (A) Human U937 cells were infected with RSV (1 MOI) in the
presence of either DMSO (control) or NF-kB inhibitor (BAY 11-7082). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h
post-infection. (B) RT-PCR analysis of pro-IL-1b, caspase-1 and NLRP3 expression in U937 cells infected with RSV in the presence of either DMSO
(control) or BAY 11-7082. (C) Wild type primary mouse bone marrow derived macrophages (BMDM) were infected with RSV (1 MOI) in the presence of
either DMSO (control) or BAY 11-7082. IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. (D) RT-PCR
analysis of pro-IL-1b, ASC and NLRP3 expression in WT BMDMs infected with RSV in the presence of either DMSO (control) or BAY 11-7082. The gels
shown in (B) and (D) are representative of three independent experiments that yielded similar results. For ELISA results, each value represents the
mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0029695.g005
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from RSV infected cells.
In order to study the role of TLR pathway in IL-1b secretion,
we utilized primary mouse BMDMs lacking TLR2, TLR4 and
MyD88 expression. We decided to focus on TLR2/4 since these
TLRs are activated by RSV in immune cells like macrophages
[56–58] and previous studies have shown that TLR2/4 are
involved in IL-1b secretion during infection with other pathogens
[53–55]. BMDM prepared from WT, TLR2 KO, TLR4 KO and
MyD88 KO mice were infected with RSV. At 12 h and 24 h post-
infection time-points, medium supernatant was collected to assess
IL-1b levels by ELISA. Surprisingly, our studies revealed that
TLR2/MyD88 pathway is critical for IL-1b production; whereas
the role of TLR4 during this process is minimal. We observed
significantly reduced IL-1b levels in the medium supernatant
derived from RSV infected TLR2 KO and MyD88 KO BMDM
compared to infected WT and TLR4 BMDM (Fig. 6A, 6B).
The mechanism of TLR2/MyD88 pathway mediated IL-1b
release was next examined. Based on our data showing NF-kB
dependent pro-IL-1b and NLRP3 gene expression during RSV
infection (Fig. 5); we postulated that activation of TLR2/MyD88
by RSV results in NF-kB activation and subsequent expression of
essential genes like pro-IL-1b and NLRP3. Indeed, TLR2/
MyD88 pathway is absolutely critical for pro-IL-1b and NLRP3
gene expression during RSV infection. RT-PCR analysis revealed
drastic loss of pro-IL-1b (Fig. 6B) and NLRP3 (Fig. 6C) mRNAs in
RSV infected TLR2 KO and MyD88 KO cells. In contrast,
caspase-1 expression was unaltered in TLR2 KO and MyD88 KO
BMDMs (Fig. 6C). Thus our studied have identified TLR2/
MyD88/NF-kB pathway as the crucial ‘‘first signal’’ required for
expression of pro-IL-1b and NLRP3 genes during RSV infection.
ROS generated during RSV infection promotes IL-1b
secretion
Next, we investigated the ‘‘second signal’’ that initiates
inflammasome assembly and release of mature IL-1b. First, we
focused on the role of ROS in IL-1b production, since – a) ROS
triggers NLRP3/ASC inflammasome formation during various
conditions [14–19,25,29,36,59–65], b) ROS is required for
NLRP3/ASC inflammasome mediated IL-1b secretion during
influenza A virus infection [31], c) RSV infection results in
intracellular ROS production [66,67]. The role of ROS was
examined by using ROS inhibitor DPI [68] and ROS scavenger
APDC [25,36]. Both these ROS inhibitors/scavengers were
utilized previously to study NLRP3/ASC inflammasome depen-
dent IL-1b production [25,36,68]. For our studies, we pre-treated
U937 cells with DPI (10 mM) and APDC (50 mM) for 2 h, followed
by RSV infection in the presence of the inhibitors or vehicle
control (water for APDC and DMSO for DPI). At 12 h and 24 h
post-infection, IL-1b levels in the medium supernatant were
measured by ELISA. ROS play a vital role in IL-1b secretion
during RSV infection, since treatment of cells with DPI and
APDC lead to 41%–56% inhibition in IL-1b release from RSV
infected cells (Fig. 7A, 7B).
The role of ROS was further verified using primary BMDM.
Initially we incubated BMDM with 10 mM DPI during RSV
infection. However, we observed significant decrease in NLRP3
and IL-1b expression following 10 mM DPI treatment (data not
Figure 6. TLR2/MyD88 pathway is required for IL-1b release during RSV infection. (A) Wild type (WT), TLR2 knock-out (KO) and TLR4 KO
BMDMs were infected with RSV (1 MOI). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. (B) Wild type
(WT) and MyD88 knock-out (KO) BMDMs were infected with RSV (1 MOI). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and
24 h post-infection. (C) RT-PCR analysis of pro-IL-1b expression in RSV infected WT, TLR2 KO and MyD88 KO BMDMs. (D) RT-PCR analysis of caspase-1
and NLRP3 expression in RSV infected WT, TLR2 KO and MyD88 KO BMDMs. The gels shown in (C) and (D) are representative of three independent
experiments that yielded similar results. For ELISA assay, each value represents the mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0029695.g006
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whereby 10 mM-20 mM DPI significantly reduced expression of
pro-IL-1b and NLRP3 genes in BMDM. In contrast, it was shown
that 1 mM-2 mM DPI did not effect NLRP3 expression and IL-1b
protein levels in BMDM [68]. Therefore, we treated BMDM with
2 mM DPI, which did not alter NLRP3 gene expression and
intracellular IL-1b levels (data not shown). Incubation of WT
BMDM with DPI (2 mM) resulted in significant reduction (by
56%–70%) in IL-1b production upon RSV infection, compared to
control (DMSO treated) cells (Fig. 7C). Please note that DPI
(2 mM) and APDC (50 mM) concentrations used in the current
study is similar (or lower) compared to concentrations used to in
previous studies dealing with the role of ROS in inflammasome
activation in macrophages [25,68]. We have thus identified ROS
as one of the crucial intracellular signal that promotes inflamma-
some activation and IL-1b release from RSV infected cells.
IL-1b release during RSV infection requires potassium
efflux by ATP-sensitive potassium channel
Since loss of ROS did not completely abrogate IL-1b
production following RSV infection (Fig. 7), we speculated that
additional mechanism is required for inflammasome activation.
Since RSV infection results in extracellular release of ATP and
UTP [69,70], we postulated that potassium efflux by ATP-
sensitive potassium channel may constitute an additional ‘‘second
signal’’. In order to study the contribution of potassium efflux in
IL-1b production, we inhibited ATP-sensitive potassium channel
with glibenclamide. We used non-toxic concentration (50 mM) of
glibenclamide as previously reported for studying the role of ATP-
sensitive potassium channel in inflammasome activation in
macrophages [25,71,72]. WT BMDMs were pretreated with
glibenclamide (50 mM) for 1 h, followed by RSV infection in the
presence of glibenclamide or DMSO (vehicle control). IL-1b levels
in the medium supernatant were measured by ELISA at 12 h post-
infection. As expected, glibenclamide dramatically blocked (by
88%) IL-1b release from LPS/ATP treated cells (Fig. 8A). ATP-
sensitive potassium channel is also required for IL-1b secretion
during RSV infection, since significantly less (inhibited by
approximately 60%) IL-1b was released from infected cells treated
with glibenclamide (Fig. 8A). Glibenclamide treatment did not
alter expression of pro-IL-1b, NLRP3 and ASC gene expression,
indeed pro-IL-1b and NLRP3 expression was enhanced in
glibenclamide treated cells (Fig. S4A).
To further validate a role of potassium efflux in inflammasome
activation, we next infected U937 cells (Fig. 8B) or WT BMDM
(Fig. 8C) with RSV for 6 h and 12 h in the presence of buffer
containing either 150 mM NaCl (control) or 150 mM KCl [61].
This method was previously utilized for blocking potassium efflux
to study its role during silica mediated inflammasome activation
[61]. These experiments were performed for shorter infection time
Figure 7. ROS produced during RSV infection triggers IL-1b secretion. (A) U937 cells were infected with RSV (1 MOI) in the presence of ROS
inhibitor APDC (50 mM). Water served as the vehicle control. IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-
infection. (B) U937 cells were infected with RSV (1 MOI) in the presence of ROS inhibitor DPI (10 mM). DMSO served as the vehicle control. IL-1b levels
in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. (C) Wild type primary mouse bone marrow derived macrophages
(BMDM) were infected with RSV (1 MOI) in the presence of ROS inhibitor DPI (2 mM) or DMSO (vehicle control). IL-1b levels in the medium supernatant
were assayed by ELISA at 12 h and 24 h post-infection. Each value represents the mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0029695.g007
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prolonged exposure of cells to NaCl and KCl may induce cellular
toxicity. As shown in Fig. 8B, incubation with excess potassium
(i.e. with medium containing 150 mM KCl) resulted in significant
reduction (by 44%) in IL-1b release from RSV infected U937 cells.
Drastic loss of IL-1b release (inhibition of IL-1b secretion by 90%)
was also noted in RSV infected BMDM incubated with 150 mM
KCl buffer (Fig. 8C). As expected dramatic loss (inhibition by
95%) of IL-1b was observed from LPS and ATP treated BMDM
incubated with KCl buffer (Fig. S4B). These studies have
demonstrated that both ROS and potassium efflux (mediated by
ATP-sensitive potassium channel) is required for inflammasome
assembly and caspase-1 activation, leading to mature IL-1b
secretion from RSV infected cells.
Discussion
Innate immunity comprises the first line of defense against
invading pathogens [4–7]. IL-1b is a pyrogenic cytokine that is
produced during innate immune response following pathogenic
invasion. IL-1b plays a very important role in shaping the
inflammatory response against pathogens. Restricted inflamma-
tion is required to clear the pathogen and launch an effective
adaptive immune response. IL-1b is synthesized as an immature
pro-form (pro-IL-1b) which requires activated caspase-1 for
cleavage into mature IL-1b that is secreted from the cells.
Extracellular IL-1b confers its pro-inflammatory effect via an
autocrine/paracrine mechanism following binding to its cognate
receptor, IL-1bR.
Multimeric protein complex called inflammasome is indispen-
sible for caspase-1 activation (14–37). One of the major constituent
of the inflammasome complex is the NLR family proteins.
Recently, AIM2 was identified as an important non-NLR
inflammasome required for caspase-1 activation [73]. There is
also a report of RIGI/CARD-9 mediated inflammasome activa-
tion [74]. The assembly of specific type of inflammasome is
dictated by the nature of stimuli (or signal). Recent studies have
validated the emergence of inflammasome as a vital component
regulating health and disease [14–37]. Genetic disorders involving
activation of NLRP3 inflammasome is associated with various
inflammatory disorders. Host derived damage-associated molecu-
lar patterns (DAMPs) and endogenous molecules also activate
inflammasome, which culminates in various disease states. For
example, ATP, monosodium urate (MSU), cholesterol crystals,
Figure 8. Potassium efflux plays a critical role in IL-1b production during RSV infection. (A) Wild type primary mouse bone marrow
derived macrophages (BMDM) were infected with RSV (1 MOI) in the presence of ATP-sensitive potassium channel inhibitor glibenclamide (50 mM).
DMSO served as the vehicle control. IL-1b levels in the medium supernatant were assayed by ELISA at 12 h and 24 h post-infection. Cells were also
treated with LPS and ATP in the presence of either DMSO or glibenclamide. (B) U937 cells were infected with RSV (1 MOI) in the presence of buffer
containing either NaCl (150 mM) (control) or KCl (150 mM). IL-1b levels in the medium supernatant were assayed by ELISA at 12 h post-infection.
(C) BMDM were infected with RSV (1 MOI) in the presence of buffer containing either NaCl (150 mM) (control) or KCl (150 mM). IL-1b levels in the
medium supernatant were assayed by ELISA at 6 h and 12 h post-infection. Each value represents the mean 6 standard deviation from three
independent experiments.
doi:10.1371/journal.pone.0029695.g008
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acid and glucose activates NLRP3 inflammasome [14–37], which
contributes to disease associated with these DAMPs/molecules –
i.e. MSU (gout), amyloid beta (Alzheimer’s disease), cholesterol
crystals (atherosclerosis), IAPP and glucose (diabetes), fatty acid
(type II diabetes), hyaluronin (inflammation during tissue damage)
and ATP (chronic and atopic inflammation in the respiratory
tract). Apart from these diseases, exposure to environmental
pollutants like asbestos and silica activates NLRP3 inflammasome
to cause exaggerated inflammatory response in the airway. These
extensive studies have illustrated an essential function of
inflammasome components (e.g. NLRP3) in regulating patho-
physiological condition associated with cellular and tissue
homeostasis.
Infection with various pathogens (virus, bacteria, fungus,
parasites) also triggers inflammasome formation. Controlled pro-
inflammatory response is needed for pathogen clearance and
induction of an effective adaptive immunity. Both DNA and RNA
viruses utilizes various inflammasomes for caspase-1 activation and
IL-1b secretion. DNA viruses like vaccinia virus and mouse
cytomegalovirus utilizes AIM2/ASC inflammasome for caspase-1
activation and IL-1b release [75]. NLRP3 inflammasome serve as
the platform for caspase-1 activation (and IL-1b release) during
infection with both DNA (adenovirus, herpes virus, vaccinia virus)
and RNA (influenza A virus, mouse Sendai virus, mouse
encephalomyocarditis virus) viruses [34]. Among the human
lung-tropic viruses, a critical role of NLRP3 [30,31] and ASC
[32] inflammasome in controlling influenza A virus infection and
pathogenesis was illuminated by several studies. NLRP3/ASC
inflammasome confers optimal airway inflammation required for
influenza A virus clearance from the respiratory tract.
In infected macrophages, two discrete signals are required for
inflammasome formation and caspase-1 activation [38] – a) First
signal (signal-1) constitutes gene expression of pro-IL-1b and
components of inflammasome complex (e.g. NLRP3); which is
mediated by induction of cellular signaling pathways (e.g. NF-kB
pathway) following PRR (e.g. TLRs) activation by PAMPs (e.g.
LPS), and b) second signal (signal-2) triggers assembly of
inflammasome complex. The second signal is relayed by various
mechanism including, generation of intracellular ROS, potassium
efflux due to stimulation of ATP-sensitive potassium channel or
pore formation by bacterial toxins, lysosomal disruption leading to
cathepsin B leakage into the cytoplasm [14–19,29]. Interestingly,
ROS may also confer first signal by regulating pro-IL-1b and
NLRP3 gene expression [68]. Among the human respiratory
viruses, mechanism of inflammasome formation is only charac-
terized following influenza A virus infection [30–32,76]. Although,
the nature of first signal (required for pro-IL-1b and NLRP3 gene
expression) during influenza A virus infection is still unknown,
there is evidence for the existence of ‘‘first signal’’ during influenza
A virus infection, since in vivo (in mice) and in vitro infection with
influenza A virus resulted in induction of both pro-IL-1b and
NLRP3 gene expression [31]. At least two second signals including
ROS and endosomal ion flux (mediated by influenza A virus M2
ion channel protein) has been implicated in triggering inflamma-
some assembly flowing influenza A virus infection [31,76]. In that
context, our current studies have elucidated both the first and
second signals required for inflammasome mediated IL-1b release
during infection with another clinically important human
respiratory virus, RSV.
Similar to influenza A virus (a orthomyxovirus), RSV (a
paramyxovirus) is a single-stranded RNA respiratory virus that
causes mortality and morbidity among children, elderly and
immuno-compromised individuals [1–3]. Although RSV infection
results in IL-1b secretion [9–12], so far the mechanism is not
known. Here in, we have characterized the mechanism involved in
IL-1b secretion during RSV infection. Our results demonstrated
that – a) activated caspase-1 is required for IL-1b secretion, b)
NLRP3/ASC inflammasome complex activates caspase-1 during
RSV infection, c) TLR2/MyD88 pathway mediated NF-kB
activation is essential for expression of pro-IL-1b and NLRP3
genes (first signal), and d) ROS and potassium efflux (via
stimulation of ATP-sensitive potassium channel) generated in
RSV infected cells serves as the second signal for inflammasome
complex assembly. Based on these results we propose a model
(Fig. 9) whereby RSV infection induces TLR2/MyD88 pathway,
leading to activation of NF-kB. NF-kB translocates to the nucleus
to trans-activate pro-IL-1b and NLRP3 genes. ROS and
potassium efflux (via stimulation of ATP-sensitive potassium
channel) generated in infected cells trigger formation of
NLRP3/ASC inflammasome complex; which cleaves pro-cas-
pase-1 to generate activate caspase-1. Cleavage of pro-IL-1b
protein by activated caspase-1 results in secretion of mature
functional IL-1b. It is important to mention that as recently noted
[68], ROS may also serve as a ‘‘first signal’’ during RSV infection,
since high concentration of ROS inhibitor reduced expression of
pro-IL-1b and NLRP3 gene expression during RSV infection
(data not shown). The mechanism by which ROS is regulating
gene expression needs further characterization. Nevertheless, using
ROS inhibitor concentration that did not affect NLRP3 and pro-
IL-1b levels, we demonstrated that ROS could also function as a
‘‘second signal’’ following RSV infection. Our results have
illustrated that similar to influenza A virus [30–32], RSV also
utilizes NLRP3/ASC inflammasome for caspase-1 activation and
ROS is required during this event. However, we have extended
our studies to document that TLR2/MyD88/NF-kB pathway is
essential for expression of pro-IL-1b and NLRP3 genes (first
signal). In addition, two second signals (ROS and potassium efflux)
are required to promote inflammasome formation following RSV
infection. Thus, RSV is capable of utilizing two different PRRs
(membrane bound PRRs like TLR2 and cytoplasmic PRR like
NLRP3) to orchestrate mature IL-1b release via a NF-kB
dependent process.
The pre-requisite for IL-1b release constitute optimal expression
of pro-IL-1b and inflammasome related (e.g. NLRP3) genes (first
signal), which precedes inflammasome complex formation. So far
the first signal has not been widely characterized. Few studies have
suggested that PAMP or DAMP mediated activation of membrane
bound TLRs transduce signal to activate NF-kB for expression of
pro-IL-1b and inflammasome-related gene like NLRP3 [42–
45,51–55]. TLRs/MyD88 was required for inflammasome
assembly after infection [vaccinia virus (TLR2/6), Candida
albicans (TLR2), Vibrio (MyD88)] and stimulation with DAMPs
[biglycan (TLR2/4)], environmental particles [alkane particles
(TLR2)] or fungal components [zymosan and mannan (TLR2)]
[51–55,77]. Activated NF-kB was necessary for inflammasome
formation during infection (Streptococcus pyogenes, Vibrio)
[45,51] or stimulation with various ligands/agents (TLR4 ligand
LPS, TLR2/1 ligand Pam3CysSK4, silica) [42,43]. Specifically,
TLR/NF-kB pathway was essential for expression of pro-IL-1b
and NLRP3 genes during various conditions [42–44,51]. Although
RNA viruses (e.g. influenza A virus) utilize inflammasome for
caspase-1 activation, the ‘‘first signal’’ associated with IL-1b
release has not been elucidated. In that regard, we report that
TLR2/MyD88/NF-kB pathway serves as a crucial first signal for
pro-IL-1b and NLRP3 gene expression during RSV infection.
RSV utilizes both TLR4 and TLR2 for launching a pro-
inflammatory response during RSV infection of the macrophages
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TLR2/MyD88/NF-kB pathway as the major signaling compo-
nent responsible for expression of pro-IL-1b and NLRP3 genes
following RSV infection of macrophages. The specificity of this
pathway is borne out by the observation that TLR4 was not
involved during this process. This observation was surprising, since
TLR4 was also identified as one of the PRRs involved in pro-
inflammatory response during RSV infection of macrophages
[56,57]. However, TLR2 dependent response was predominant in
RSV infected macrophages compared to TLR4 [58]. Although
TLR2 may serve as the major PRR, other PRRs or mechanisms
could contribute to NF-kB mediated expression of pro-IL-1b and
NLRP3 genes, since RSV infection of TLR2 KO and MyD88 KO
cells did not completely abrogate IL-1b production. Moreover,
apart from NF-kB, MAPK pathways may also play a role in
expressing pro-IL-1b and NLRP3 genes because pro-IL-1b and
NLRP3 gene possess AP-1 binding site in its promoter region
(unpublished observation) and both RSV and TLR2 induce
MAPK pathway [78,79]. In the future we will investigate the
precise mechanism by which TLR2/MyD88 pathway regulate
pro-IL-1b and NLRP3 gene expression during RSV infection.
Various mediators transmit the second signal for inflammasome
complex assembly. This signal is conferred by intracellular ROS,
potassium efflux, cytoplasmic cathepsin B (leakage of cathepsin B
due to lysosomal disruption). During influenza A virus infection,
ROS and endosomal ion flux (mediated by viral M2 proton
channel) constitute the second signal for inflammasome formation
[31,76].
Our studies have illustrated that ROS produced during RSV
infection and potassium efflux due to stimulation of ATP-sensitive
potassium channel serve as the second signal to promote
inflammasome activation. RSV infection results in generation of
oxygen radicals like ROS [66,67]. Scavenging or inhibiting
intracellular ROS substantially reduced IL-1b secretion. ROS
has been implicated in caspase-1 activation during various patho-
physiological conditions like diabetes; ROS production was
essential for inflammasome formation by glucose, IPP and fatty
acids [25,36,63]. Intracellular ROS is also critical for inflamma-
some activity following exposure to pollutants (asbestos and silica)
[60,61] and infection with viruses (influenza A virus, adenovirus)
[31,65], fungus (Aspergillus fumigatus) [64] and parasites (malarial
hemozoin) [59]. It is also reported that mitochondrial ROS (in
contrast to ROS generated by NADPH oxidases or NOX) is
involved in inflammasome activation [80,81]. In that context, we
have used two ROS inhibitor/scavenger (APDC and DPI) that is
known to block NOX derived ROS and ROS originating from
mitochondria. Recently, it was shown that high concentrations
(10 mM–20 mM) of ROS inhibitors (DPI and NAC) significantly
diminished expression of pro-IL-1b and NLRP3 genes in mouse
macrophages [68]. Indeed, we also observed loss of pro-IL-1b and
NLRP3 mRNA expression by using high concentrations (i.e.
10 mM) of ROS inhibitor DPI during RSV infection (data not
shown). However, to assess the role of ROS during second signal,
we have used low (2 mM) concentrations of DPI. As previously
noted [68], 1 mM–2 mM DPI did not affected NLRP3 gene
expression and IL-1b protein levels in murine macrophages [68].
Since ROS scavengers did not completely abrogate IL-1b
secretion, we speculated that additional mechanism(s) may
contribute to inflammasome formation and caspase-1 activation
during RSV infection. Efflux of potassium is known to activate
inflammasome. Potassium efflux is achieved either by activation of
ATP-gated ion channel P2X7R by extracellular ATP or pore
formation by bacterial toxins [71,72,82–91]. Toward that end we
have identified potassium efflux due to stimulation of ATP-
sensitive ion channel as the additional second signal for IL-1b
release during RSV infection. Potassium efflux contributes to
inflammasome activation during various patho-physiological
conditions like infection with bacteria (Staphylococcus aureus,
Escherichia coli, Chlamydia, bacterial toxins) [71,82–87] or
fungus [Candida albacans, b-glucan (major cell wall components
of fungi)] [88,89], diabetes [25,36], exposure to silica [90] and
treatment with antibiotics [91]. Role of intracellular ionic
Figure 9. A schematic model depicting the mechanism of IL-1b secretion during RSV infection. RSV infection activates TLR2/MyD88
pathway that culminates in NF-kB activation. Nuclear translocation of NF-kB results in NF-kB mediated trans-activation of pro-IL-1b and NLRP3 genes.
Intracellular ROS generated during RSV infection and potassium efflux due to stimulation of ATP-sensitive ion channel triggers assembly of NLRP3/
ASC inflammasome complex. NLRP3/ASC inflammasome activates caspase-1, which subsequently cleaves pro-IL-1b protein into its mature form.
Mature IL-1b is secreted from the cells.
doi:10.1371/journal.pone.0029695.g009
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activation during virus infection has not been reported. In that
context, our study has illuminated potassium efflux as the second
signal required by RSV for inflammasome activation. Although
cathepsin B leakage due to lysosomal disintegration also activates
inflammasome [14–19,29], that phenomenon may not be
occurring during RSV infection. Cathepsin B mediated inflamma-
some activation is only noted for crystalline and particulate
molecules that activate inflammasome following cellular uptake
leading to lysosomal destabilization [14–19,29]. Moreover,
lysosomal integrity is maintained during RSV infection (data not
shown). Thus our studies have identified both ROS and potassium
efflux as the key second signals essential for inflammasome
activation during RSV infection. It is interesting to note that
similar to RSV, there is precedence for inflammasome activation
by two second signals. For example, b-glucan, candida albican and
silica mediated inflammasome activation requires both ROS and
potassium efflux [88–90].
Please note that we failed to detect significant difference in RSV
infectivity (examined by performing plaque assay to determine
viral titer) in control cells vs. cells treated with various inhibitors
(i.e. ROS inhibitors and ATP-sensitive potassium channel
inhibitor) (data not shown). Similarly, no difference in RSV titer
was observed in WT vs. KO cells (i.e. NLRP3 KO, caspase-1 KO
and ASC KO BMDMs) (data not shown).
In summary, we have characterized the mechanism of IL-1b
secretion during RSV infection. IL-1b release during infection
requires NLRP3/ASC inflammasome complex that activates
caspase-1, the enzyme required for processing pro-IL-1b into
mature IL-1b. TLR2/MyD88/NF-kB pathway serves as the first
signal for expression of pro-IL-1b and NLRP3 genes. The second
signal comprising of both ROS and potassium efflux promotes
inflammasome activation.
Materials and Methods
Virus and cells
RSV (A2 strain) was propagated in CV-1 cells [40,46–48]. RSV
was purified by centrifugation (two times) on discontinuous sucrose
gradients as described previously [92]. 293 cells were maintained in
DMEM supplemented with 10% fetal bovine serum (FBS),
penicillin, streptomycin, and glutamine. U937 cells were maintained
in RPMI 1640 medium supplemented with 10% FBS, 100 IU/mL
Penicillin, 100 mg/mL Streptomycin, 1 mM sodium pyruvate and
100 nM HEPES. Bone marrow-derived macrophages (BMDMs)
were obtained from femurs and tibias of wild-type WT, ASC knock-
out (KO), NLRP3 KO, TLR2 KO, TLR4 KO and MyD88 KO
mice and were cultured for 6–8 days as described earlier [40,93].
Cells were plated on 6-well plates containing RPMI, 10% FBS,
100 IU/mL Penicillin, 100 mg/mL Streptomycin and 20 ng/ml
GM-CSF. Femurs and tibia (for isolation of BMDM) were provided
by our collaborator Dr. Michael Berton (University of Texas Health
Science Center), who procured the TLR2 KO, TLR4 KO and
MyD88 KO mice from Dr. Doug Golenbock (University of
Massachusetts Medical School, Worcester, MA) under a Materials
Transfer Agreement with Dr. Shizuo Akira (Osaka University,
Osaka, Japan). 293 and U937 cells were obtained from American
Type Culture Collection (ATCC), Manassas, VA.
RNA isolation, PCR amplification and reverse
transcription-PCR (RT-PCR)
Total RNA isolation from cells was performed using a
monophasic solution of phenol and guanidine thiocyanate (TRIzol)
(Sigma-Aldrich, St. Louis, MO), as recommended by the suppliers.
Total cellular RNA (,1 mg) was used to generate cDNA using
Moloney murine leukemia virus reverse transcriptase (Applied
Biosystems, Carlsbad, CA). PCR was routinely performed using
0.25 units of Taq polymerase, 10 pmol of each oligonucleotide
primer, 1 mM MgCl2, and 100 mM deoxynucleotide triphosphates
in a final reaction volume of 25 ml. The amplification cycle was as
follows: An initial denaturing step (95uC for 3–5 min) was followed
by either 25, 30 or 35 cycles of denaturing (94uC for 30 sec),
annealing (60uC for 30 s), and extending (72uC for 30 sec), followed
by either 5 or 10 min at 72uC for elongation. Following
amplification, the PCR products were analyzed on 2% agarose
gels and band intensities were quantified by densitometry (Syngene
gel-documentation system). Equal loading in each well was
confirmed by analyzing expression of the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The prim-
ers used to detect the indicated genes by RT-PCR are shown below.
Human ASC- Forward (59-39) GGACGCCTTGGCCCTCA-
CCG, Reverse (59-39) GGCGCGGCTCCAGAGCCCTG (prod-
uct size 2150 bp)
Human NLRP3- Forward (59-39) TTCTTTCTGTTTGCTG-
AGTTTTTG, Reverse (59-39) TTCCTGGCATATCACAGTGG
(product size 2467 bp)
Human caspase-1- Forward (59-39) ATCCGTTCCATGGGT-
GAAGGTACA, Reverse (59-39) CAAATGCCTCCAGCTCT-
GTA (product size 2616 bp)
Human pro-IL-1b- Forward (59-39) AAACAGATGAAG-
TGCTCCTTCCAG, Reverse (59-39) TGGAGAACACCACT-
TGTTGCTCCA (product size 2391 bp)
Human GAPDH- Forward (59-39) GTCAGTGGTGGACCT-
GACCT, Reverse (59-39) AGGGGTCTACATGGCAACTG
(product size 2420 bp)
Mouse ASC- Forward (59-39) GTGGACGGAGTGCTGGA-
TG, Reverse (59-39) GTCCATCACCAAGTAGGGATG (prod-
uct size 2189 bp)
Mouse NLRP3- Forward (59-39) CTGAAGATGACGAGT-
GTCCGTT, Reverse (59-39) ATGCTGCAGTTTCTCCAAG-
GCT (product size 21074 bp)
Mouse Caspase-1- Forward (59-39) TCCAGGAGGGAATA-
TGTGG, Reverse (59-39) CTTGTTTCTCTCCACGGCA (prod-
uct size 2156 bp)
Mouse pro-IL-1b- Forward (59-39) GACAGTGATGAGAAT-
GACCTGTTC, Reverse (59-39) CCTGACCACTGTTGTTT-
CCC (product size 2730 bp)
Mouse GAPDH- Forward (59-39) GCCAAGGTCATCCAT-
GACAACTTTGG, Reverse (59-39) GCCTGCTTCACCACCT-
TCTTGATGTC (product size 2314 bp)
ELISA assay for IL-1b
Medium supernatant collected from RSV infected macrophages
or 293 cells were analyzed for IL-1b levels by using human or
mouse IL-1b specific ELISA kit (eBioscience, San Diego, CA).
293 cell transfection
293 cells were transfected (Lipofectamine 2000 from Invitrogen
was used for transfection) at 80% confluence [40] with expression
plasmids encoding human pro-IL-1b (0.1 mg/well of 12-well
plate), pro-caspase-1 (1.5 mg/well of 12-well plate), ASC (1 mg/
well of 12-well plate), NLRP3 (1 mg/well of 12-well plate) or
pcDNA6.1 (1 mg/well of 12-well plate). At 24 h post-transfection,
293 cells were infected with RSV (1 MOI).
Viral infection of cells
293 cells, U937 cells and BMDM were infected with purified
RSV at 1 multiplicity of infection (MOI) in serum free antibiotic
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performed for 1.5 h at 37uC. For 293 cells, following adsorption,
cells were washed twice with serum containing DMEM and the
infection was continued in the presence of serum containing
DMEM for the specified time points. For U937 cells, following
adsorption, cells were washed twice with serum containing RPMI
medium and infection was continued in RPMI medium
supplemented with 10% FBS, 100 IU/mL Penicillin, 100 mg/
mL Streptomycin, 1 mM sodium pyruvate and 100 nM HEPES.
For BMDM, following adsorption, cells were washed twice with
serum containing RPMI medium and infection was continued in
RPMI medium containing 10% FBS, 100 IU/mL Penicillin,
100 mg/mL Streptomycin and 20 ng/ml GM-CSF.
In some experiments, U937 cells and WT BMDM were pre-
treated (for 2 h) with either caspase-1 inhibitors [Ac-(NMe)Tyr-
Val-Ala-Asp-CHO (Ac-YVAD-CHO) (10 mM) (AnaSpec, Fre-
mont, CA)], NF-kB inhibitor BAY 11-7082 (5 mM) (Sigma-
Aldrich, St. Louis, MO), ROS inhibitors/scavengers [(2R,4R)-4
Aminopyrrolidine-2,4-dicarboxylic acid (APDC) (50 mM) (Enzo
Life sciences, Plymouth Meeting, PA) or Diphenyleneiodonium
Chloride (DPI) (10 mMo r2mM) (EMD Bioscienes, Rockland,
MA)], ATP-sensitive potassium channel inhibitor Glibenclamide
(50 mM) (Sigma-Aldrich, St. Louis, MO). After pre-treatment, cells
were infected with RSV in the absence or presence of the
corresponding inhibitors. As a vehicle control either DMSO or
water was used. For the experiment with glibenclamide cells were
treated with LPS+ATP as a positive control. Cells were primed
with LPS (5 mg/ml) (Invivogen, San Diego, CA) followed by
addition of ATP (5 mM) (Sigma-Aldrich, St. Louis, MO) in the
presence of DMSO or glibenclamide.
For some experiments, cells were infected in the presence of
150 mM KCl or 150 mM NaCl. U937 cells or BMDMs were pre-
treated for 30 min with a buffer containing either 150 mM KCl
(10 mM HEPES, 5 mM NaH2PO4, 150 mM KCl, 1 mM MgCl2,
1m MC a C l 2,1%BSA,pH 7.4)or150 mMNaCl(10 mMHEPES,
5m MK H 2PO4, 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2,1 %
BSA, pH 7.4). Following pretreatment, cells were infected with
purified RSV at 1 MOI in serum-free antibiotic free OPTI-MEM I.
Following adsorption for 1 h at 37uC, OPTI-MEM containing RSV
was replaced with fresh buffer containing either 150 mM KCl or
150 mM NaCl. At 6 h and 12 h post-infection, the medium
supernatant was collected to measure IL-1b protein levels by
ELISA. Cells were treated with LPS+ATP as a positive control.
BMDM incubated with buffer containing either 150 mM NaCl or
150 mM KCl were primed with LPS (5 mg/ml) (Invivogen, San
Diego, CA) for 12 h followed by addition of ATP (5 mM) (Sigma-
Aldrich, St. Louis, MO). Following 30 min ATP treatment, medium
supernatant wascollected tomeasureIL-1b proteinlevelsby ELISA.
Caspase-1 p10 subunit Western blotting
Total cell lysate collected from RSV infected cells were used for
Western blotting. Cell lysate (50 mg protein) was subjected to 12%
SDS-PAGE. The separated proteins were transferred to PVDF
membrane and blotted with antibody specific for either human or
mouse caspase-1 p10 subunit. Both the human and mouse p10
antibodies were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). In some experiment the blot was stripped with Western
blot stripping buffer (Thermo Scientific, Rockford, IL) and re-probed
with anti-actin antibody (Bethyl Laboratories, Montgomery, TX).
Supporting Information
Figure S1 (A) RT-PCR analysis of caspase-1 expression
in mock and RSV infected 293 cells. Caspase-1 expression
was also monitored in RSV infected (at 24 h post-infection) 293
cells transfected with pro-caspase-1 plasmid (pro-caspase-1
transfected). (B) RT-PCR analysis of pro-IL-1b expression in
mock and RSV infected 293 cells. Pro-IL-1b expression was
also monitored in RSV infected (at 24 h post-infection) 293
cells transfected with pro-IL-1b plasmid (pro-IL-1b transfected).
(C) RT-PCR analysis of NLRP3 expression in mock and RSV
infected 293 cells. NLRP3 expression was also monitored in RSV
infected (at 24 h post-infection) 293 cells transfected with NLRP3
plasmid (NLRP3 transfected).
(TIF)
Figure S2 Primary normal human bronchial epithelial
(NHBE) cells were infected with RSV (1 MOI) in the
presence of either water (vehicle control) or caspase-1
inhibitor (10 mM of Ac-YVAD-CHO). IL-1b levels in the
medium supernatant were assayed by ELISA at 12 h post-
infection. Each value represents the mean 6 standard deviation
from three independent experiments.
(TIF)
Figure S3 Wild type (WT), NLRP3 knock-out (KO) and
ASC KO BMDMs were infected with RSV (1 MOI) for
12 h. The cell lysate from mock infected and RSV infected cells
were subjected to Western blot analysis with mouse caspase-1 p10
subunit specific antibody (as shown in Fig. 4A). The blot was
stripped and re-probed with anti-actin antibody.
(TIF)
Figure S4 (A) RT-PCR analysis of pro-IL-1b, ASC, and
NLRP3 expression in RSV infected wild type primary
mouse bone marrow derived macrophages (BMDM)
treated with either DMSO or glibenclamide (Gliben)
(50 mM). (B) WT BMDMs were treated with LPS+ATP (primed
with LPS for 12 h, followed by stimulation with ATP for 30 mins)
in the presence of buffer containing either 150 mM NaCl (control)
or 150 mM KCl. IL-1b levels in the medium supernatant were
assayed by ELISA. Each value represents the mean 6 standard
deviation from three independent experiments.
(TIF)
Author Contributions
Conceived and designed the experiments: JS AS VM SYT SB. Performed
the experiments: JS AS VM SYT THC IRM. Analyzed the data: JS AS
VM SYT THC SB. Contributed reagents/materials/analysis tools: MTB
ICA JPYT. Wrote the paper: SB JS AS.
References
1. Hall CB (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med
344: 1917–1928.
2. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia.
Lancet 377(9773): 1264–1275.
3. Collins PL, Chanock RM, Murphy BR (2001) Respiratory syncytial virus. In:
Knipe DM, Howley PM, eds. Fields Virology, 4
th ed, Lippincott Williams &
Wilkins: Philadelphia, PA. pp 1443–1486.
4. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat
Immunol 7: 131–137.
5. Bose S, Banerjee AK (2003) Innate immune response against nonsegmented
negative strand RNA viruses. J Interferon Cytokine Res 23: 401–412.
6. O’Neill LA, Bowie AG (2010) Sensing and signaling in antiviral innate
immunity. Curr Biol 20(7): R328–333. Review.
7. Rathinam VA, Fitzgerald KA (2010) Inflammasomes and anti-viral immunity.
J Clin Immunol 30(5): 632–637.
8. Schmitz N, Kurrer M, Bachmann MF, Kopf M (2005) Interleukin-1 is
responsible for acute lung immunopathology but increases survival of respiratory
influenza virus infection. J Virol 79: 6441–6448.
Inflammasome Activation during RSV Infection
PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e296959. Blanco JC, Richardson JY, Darnell ME, Rowzee A, Pletneva L, et al. (2002)
Cytokine and chemokine gene expression after primary and secondary
respiratory syncytial virus infection in cotton rats. J Infect Dis 185: 1780–1785.
10. Guerrero-Plata A, Casola A, Garofalo RP (2005) Human metapneumovirus
induces a profile of lung cytokines distinct from that of respiratory syncytial virus.
J Virol 79: 14992–14997.
11. Lindgren C, Gro ¨gaard J (1996) Reflex apnoea response and inflammatory
mediators in infants with respiratory tract infection. Acta Paediatr 85: 798–803.
12. Bermejo-Martin JF, Garcia-Arevalo MC, De Lejarazu RO, Ardura J, Eiros JM,
et al. (2007) Predominance of Th2 cytokines, CXC chemokines and innate
immunity mediators at the mucosal level during severe respiratory syncytial virus
infection in children. Eur Cytokine Netw 18: 162–167.
13. Becker CE, Creagh EM, O’Neill LA (2009) Rab39a binds caspase-1 and is
required for caspase-1-dependent interleukin-1b secretion. Biol Chem 284(50):
34531–34537.
14. Davis BK, Wen H, Ting JP (2011) The inflammasome NLRs in immunity,
inflammation, and associated diseases. Annu Rev Immunol 29: 707–735.
15. Bryant C, Fitzgerald KA (2009) Molecular mechanisms involved in inflamma-
some activation. Trends Cell Biol 19(9): 455–464.
16. Franchi L, Eigenbrod T, Mun ˜oz-Planillo R, Nun ˜ez G (2009) The inflamma-
some: a caspase-1-activation platform that regulates immune responses and
disease pathogenesis. Nat Immunol 10(3): 241–247.
17. Lamkanfi M, Dixit VM (2009) The inflammasomes. PLoS Pathog 5(12):
e1000510.
18. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6): 821–832.
19. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the
body. Annu Rev Immunol 27: 229–265.
20. Jha S, Ting JP (2009) Inflammasome-associated nucleotide-binding domain,
leucine-rich repeat proteins and inflammatory diseases. J Immunol 183(12):
7623–7629.
21. Ye Z, Ting JP (2008) NLR, the nucleotide-binding domain leucine-rich repeat
containing gene family. Curr Opin Immunol 20(1): 3–9.
22. Franchi L, Warner N, Viani K, Nun ˜ez G (2009) Function of Nod-like receptors
in microbial recognition and host defense. Immunol Rev 227(1): 106–128.
23. Tannahill GM, O’Neill LA (2011) The emerging role of metabolic regulation in
the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS
Lett 585(11): 1568–1572.
24. Masters SL, Latz E, O’Neill LA (2011) The inflammasome in atherosclerosis and
type 2 diabetes. Sci Transl Med 3(81): 81ps17.
25. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, et al. (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a
mechanism for enhanced IL-1b in type 2 diabetes. Nat Immunol 11(10):
897–904.
26. Franchi L, Mun ˜oz-Planillo R, Reimer T, Eigenbrod T, Nu ´n ˜ez G (2010)
Inflammasomes as microbial sensors. Eur J Immunol 40(3): 611–615.
27. Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for
metabolic danger? Science 327(5963): 296–300.
28. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, et al. (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin
resistance. Nat Med 17(2): 179–188.
29. Jin C, Flavell RA (2010) Molecular mechanism of NLRP3 inflammasome
activation. J Clin Immunol 30(5): 628–631.
30. Thomas PG, Dash P, Aldridge JR, Jr., Ellebedy AH, Reynolds C, et al. (2009)
The intracellular sensor NLRP3 mediates key innate and healing responses to
influenza A virus via the regulation of caspase-1. Immunity 30(4): 566–575.
31. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, et al. (2009)
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A
virus through recognition of viral RNA. Immunity 30(4): 556–565.
32. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome
recognition of influenza virus is essential for adaptive immune responses. J Exp
Med 206(1): 79–87.
33. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, et al. (2006)
Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral
infection and double-stranded RNA. J Biol Chem 281(48): 36560–36568.
34. Kanneganti TD (2010) Central roles of NLRs and inflammasomes in viral
infection. Nat Rev Immunol 10(10): 688–698.
35. Rajama ¨ki K, Lappalainen J, Oo ¨rni K, Va ¨lima ¨ki E, Matikainen S, et al. (2010)
Cholesterol crystals activate the NLRP3 inflammasome in human macrophages:
a novel link between cholesterol metabolism and inflammation. PLoS One 5(7):
e11765.
36. Wen H, Gris D, Lei Y, Jha S, Zhang L, et al. (2011) Fatty acid-induced NLRP3-
ASC inflammasome activation interferes with insulin signaling. Nat Immunol
12(5): 408–415.
37. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, et al. (2010) NLRP3
inflammasomes are required for atherogenesis and activated by cholesterol
crystals. Nature 464(7293): 1357–1361.
38. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, et al. (2009)
Differential requirement for the activation of the inflammasome for processing
and release of IL-1b in monocytes and macrophages. Blood 113(10): 2324–2335.
39. O’Neill LA (2006) How Toll-like receptors signal: what we know and what we
don’t know. Curr Opin Immunol 18: 3–9.
40. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, et al. (2009)
Activation of innate immune antiviral responses by Nod2. Nat Immunol 10(10):
1073–1080.
41. Duncan JA, Gao X, Huang MT, O’Connor BP, Thomas CE, et al. (2009)
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the
signaling activities of the NLRP3 and ASC-containing inflammasome.
J Immunol 182(10): 6460–6469.
42. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, et al. (2009)
NF-kB activating pattern recognition and cytokine receptors license NLRP3
inflammasome activation by regulating NLRP3 expression. J Immunol 183(2):
787–791.
43. Franchi L, Eigenbrod T, Nunez G (2009) Cutting edge: TNF-a mediates
sensitization to ATP and silica via the NLRP3 inflammasome in the absence of
microbial stimulation. J Immunol 183: 792–796.
44. O’Connor W, Jr., Harton JA, Zhu X, Linhoff MW, Ting JP (2003) Cutting edge:
CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible
inflammatory mediator with NF-kB suppressive properties. J Immunol 171:
6329–6333.
45. Harder J, Franchi L, Mun ˜oz-Planillo R, Park JH, Reimer T, et al. (2009)
Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires
streptolysin O and NF-kB activation but proceeds independently of TLR
signaling and P2X7 receptor. J Immunol 183(9): 5823–5829.
46. Bose S, Kar N, Maitra R, Didonato J, Banerjee AK (2003) Temporal activation
of NF-kB regulates an interferon independent innate anti-viral response against
cytoplasmic RNA viruses. Proc Natl Acad Sci U S A 100: 10890–10895.
47. Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, et al. (2008) Role of
human beta-defensin-2 during tumor necrosis factor-alpha/NF-kB mediated
innate anti-viral response against human respiratory syncytial virus. J Biol Chem
283: 22417–22429.
48. Echchgadda I, Kota S, DeLa Cruz I, Sabbah A, Chatterjee B, et al. (2009) Anti-
cancer oncolytic activity of respiratory syncytial virus. Cancer Gene Ther 16:
923–935.
49. Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, et al. (2002) Identification
of NF-kB-dependent gene networks in respiratory syncytial virus-infected cells.
J Virol 76(13): 6800–6814.
50. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, et al. (1996)
Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus
involves activation of nuclear factor (NF)- kB and NF-IL-6. J Infect Dis 174(2):
262–7.
51. Toma C, Higa N, Koizumi Y, Nakasone N, Ogura Y, et al. (2010) Pathogenic
Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-
binding oligomerization domain-mediated NF-kB signaling. J Immunol 184(9):
5287–5297.
52. Lamkanfi M, Malireddi RK, Kanneganti TD (2009) Fungal zymosan and
mannan activate the cryopyrin inflammasome. J Biol Chem 284(31):
20574–20581.
53. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O,
et al. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome
via toll-like (TLR2/4) and P2X receptors. J Biol Chem 284(36): 24035–24048.
54. Delaloye J, Roger T, Steiner-Tardivel QG, Le Roy D, Knaup Reymond M,
et al. (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is
mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS
Pathog 5(6): e1000480.
55. van de Veerdonk FL, Joosten LA, Devesa I, Mora-Montes HM, Kanneganti TD,
et al. (2009) Bypassing pathogen-induced inflammasome activation for the
regulation of interleukin-1b production by the fungal pathogen Candida
albicans. J Infect Dis 199(7): 1087–1096.
56. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, et al.
(2001) Involvement of toll-like receptor 4 in innate immunity to respiratory
syncytial virus. J Virol 75(22): 10730–10737.
57. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. (2000) Pattern
recognition receptors TLR4 and CD14 mediate response to respiratory syncytial
virus. Nat Immunol 1(5): 398–401.
58. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, et al. (2009)
Respiratory syncytial virus activates innate immunity through Toll-like receptor
2. J Virol 83(3): 1492–1500.
59. Dostert C, Guarda G, Romero JF, Menu P, Gross O, et al. (2009) Malarial
hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4:
e6510.
60. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, et al. (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and
silica. Science 320: 674–677.
61. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. (2008) The
Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad
Sci U S A 105: 9035–9040.
62. Meissner F, Molawi K, Zychlinsky A (2008) Superoxide dismutase 1 regulates
caspase-1 and endotoxic shock. Nat Immunol 9: 866–872.
63. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-
interacting protein links oxidative stress to inflammasome activation. Nat
Immunol 11: 136–140.
64. Saı ¨d-Sadier N, Padilla E, Langsley G, Ojcius DM (2010) Aspergillus fumigatus
stimulates the NLRP3 inflammasome through a pathway requiring ROS
production and the Syk tyrosine kinase. PLoS One 5(4): e10008.
65. Barlan AU, Griffin TM, McGuire KA, Wiethoff CM (2011) Adenovirus
membrane penetration activates the NLRP3 inflammasome. J Virol 85(1):
146–155.
Inflammasome Activation during RSV Infection
PLoS ONE | www.plosone.org 14 January 2012 | Volume 7 | Issue 1 | e2969566. Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP, et al. (2004) Reactive
oxygen species mediate virus-induced STAT activation: role of tyrosine
phosphatases. J Biol Chem 279(4): 2461–2469.
67. Castro SM, Guerrero-Plata A, Suarez-Real G, Adegboyega PA, Colasurdo GN,
et al. (2006) Antioxidant treatment ameliorates respiratory syncytial virus-
induced disease and lung inflammation. Am J Respir Crit Care Med 174(12):
1361–1369.
68. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nu ´n ˜ez G, et al. (2011) Reactive
Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3
Inflammasome. J Immunol 187(2): 613–617.
69. Okada SF, Zhang L, Kreda SM, Abdullah LH, Davis CW, et al. (2011) Coupled
Nucleotide and Mucin Hypersecretion from Goblet Cell Metaplastic Human
Airway Epithelium. Am J Respir Cell Mol Biol 45(2): 253–260.
70. Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, et al.
(2006) Leflunomide prevents alveolar fluid clearance inhibition by respiratory
syncytial virus. Am J Respir Crit Care Med 173(6): 673–682.
71. Abdul-Sater AA, Koo E, Ha ¨cker G, Ojcius DM (2009) Inflammasome-
dependent caspase-1 activation in cervical epithelial cells stimulates growth of
the intracellular pathogen Chlamydia trachomatis. J Biol Chem 284(39):
26789–26796.
72. Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1b secretion
stimulated by P2X7 receptors is dependent on inflammasome activation and
correlated with exosome release in murine macrophages. J Immunol 179(3):
1913–1925.
73. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al.
(2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating
inflammasome with ASC. Nature 458(7237): 514–518.
74. Poeck H, Bscheider M, Gross O, Finger K, Roth S, et al. (2010) Recognition of
RNA virus by RIG-I results in activation of CARD9 and inflammasome
signaling for interleukin 1b production. Nat Immunol 11(1): 63–69.
75. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, et al. (2010) The
AIM2 inflammasome is essential for host defense against cytosolic bacteria and
DNA viruses. Nat Immunol 11(5): 395–402.
76. Ichinohe T, Pang IK, Iwasaki A (2010) Influenza virus activates inflammasomes
via its intracellular M2 ion channel. Nat Immunol 11(5): 404–410.
77. Maitra R, Clement CC, Scharf B, Crisi GM, Chitta S, et al. (2009) Endosomal
damage and TLR2 mediated inflammasome activation by alkane particles in the
generation of aseptic osteolysis. Mol Immunol 47(2–3): 175–184.
78. Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, et al. (2002)
MAPK activation is involved in posttranscriptional regulation of RSV-induced
RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283(2):
L364–372.
79. Chen W, Monick MM, Carter AB, Hunninghake GW (2000) Activation of
ERK2 by respiratory syncytial virus in A549 cells is linked to the production of
interleukin 8. Exp Lung Res 26(1): 13–26.
80. Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in
NLRP3 inflammasome activation. Nature 469(7329): 221–225.
81. Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive
proinflammatory cytokine production. J Exp Med 208(3): 417–420.
82. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG (2006) Caspase-1
activation of lipid metabolic pathways in response to bacterial pore-forming
toxins promotes cell survival. Cell 126(6): 1135–1145.
83. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, et al. (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature
440(7081): 228–232.
84. Chu J, Thomas LM, Watkins SC, Franchi L, Nu ´n ˜ez G, et al. (2009) Cholesterol-
dependent cytolysins induce rapid release of mature IL-1b from murine
macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner.
J Leukoc Biol 86(5): 1227–1238.
85. Franchi L, Kanneganti TD, Dubyak GR, Nu ´n ˜ez G (2007) Differential
requirement of P2X7 receptor and intracellular K+ for caspase-1 activation
induced by intracellular and extracellular bacteria. J Biol Chem 282(26):
18810–18818.
86. Wickliffe KE, Leppla SH, Moayeri M (2008) Anthrax lethal toxin-induced
inflammasome formation and caspase-1 activation are late events dependent on
ion fluxes and the proteasome. Cell Microbiol 2008 10(2): 332–343.
87. Fink SL, Bergsbaken T, Cookson BT (2008) Anthrax lethal toxin and Salmonella
elicit the common cell death pathway of caspase-1-dependent pyroptosis via
distinct mechanisms. Proc Natl Acad Sci U S A 105(11): 4312–4317.
88. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschla ¨ger N, et al. (2009) Syk
kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host
defence. Nature 459(7245): 433–436.
89. Kankkunen P, Teirila ¨ L, Rintahaka J, Alenius H, Wolff H, et al. (2010) (1,3)-
beta-glucans activate both dectin-1 and NLRP3 inflammasome in human
macrophages. J Immunol 184(11): 6335–6342.
90. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. (2008) The
Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad
Sci U S A 105(26): 9035–9040.
91. Allam R, Darisipudi MN, Rupanagudi KV, Lichtnekert J, Tschopp J, et al.
(2011) Cyclic polypeptide and aminoglycoside antibiotics trigger IL-1b secretion
by activating the NLRP3 inflammasome. J Immunol 186(5): 2714–2718.
92. Ueba O (1978) Respiratory syncytial virus - concentration and purification of the
infectious virus. Acta Med Okayama 32: 265–272.
93. Racoosin EL, Swanson JA (1989) Macrophage colony stimulating factor (rM-
CSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med
170: 1635–1648.
Inflammasome Activation during RSV Infection
PLoS ONE | www.plosone.org 15 January 2012 | Volume 7 | Issue 1 | e29695